32.36
price down icon5.71%   -1.96
pre-market  Vorhandelsmarkt:  33.70   1.34   +4.14%
loading
Schlusskurs vom Vortag:
$34.32
Offen:
$34.24
24-Stunden-Volumen:
526.35K
Relative Volume:
0.45
Marktkapitalisierung:
$277.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-2.8739
EPS:
-11.26
Netto-Cashflow:
$-114.09M
1W Leistung:
+1.19%
1M Leistung:
+8.23%
6M Leistung:
-47.09%
1J Leistung:
-76.03%
1-Tages-Spanne:
Value
$32.36
$34.49
1-Wochen-Bereich:
Value
$31.35
$37.42
52-Wochen-Spanne:
Value
$7.31
$137.00

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile

Name
Firmenname
Tonix Pharmaceuticals Holding Corp
Name
Telefon
212-980-9155
Name
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
Mitarbeiter
81
Name
Twitter
@TONIXPharma
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
TNXP's Discussions on Twitter

Vergleichen Sie TNXP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
32.36 277.66M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.87 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
509.72 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
309.70 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.15 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
247.08 28.51B 3.81B -644.79M -669.77M -6.24

Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-04-18 Eingeleitet Noble Capital Markets Outperform
2019-04-18 Hochstufung ROTH Capital Neutral → Buy
2017-08-18 Hochstufung ROTH Capital Neutral → Buy
2016-09-07 Herabstufung ROTH Capital Buy → Neutral
2016-02-17 Bestätigt Oppenheimer Outperform
2015-11-04 Eingeleitet Cantor Fitzgerald Buy
2015-06-12 Eingeleitet Oppenheimer Outperform
2015-02-17 Bestätigt ROTH Capital Buy
2014-09-29 Bestätigt ROTH Capital Buy
Alle ansehen

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
Jun 17, 2025

Tonix Pharmaceuticals Reports Promising Phase 3 Results for Fibromyalgia Treatment at EULAR 2025 - citybuzz -

Jun 17, 2025
pulisher
Jun 16, 2025

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Tonix Pharmaceuticals: Big Risk, Bigger RewardInitiating With A Buy (NASDAQ:TNXP) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Tonix Pharma Presents Data at Rheumatology Congress - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Tonix Pharmaceuticals (TNXP) Highlights Fibromyalgia Treatment a - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Tonix Pharmaceuticals (TNXP) Highlights Fibromyalgia Treatment at EULAR 2025 | TNXP Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Tonix Pharmaceuticals Presented Data and Analyses of - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

First New Fibromyalgia Treatment in 15 Years Shows Breakthrough Results, FDA Decision Approaches - Stock Titan

Jun 16, 2025
pulisher
Jun 14, 2025

Tonix Pharmaceuticals (TNXP) Welcomes New Board Member | TNXP St - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Tonix Pharmaceuticals Announces Appointment of Commercial - GlobeNewswire

Jun 14, 2025
pulisher
Jun 14, 2025

Tonix Pharmaceuticals Strengthens Board with Appointment of Jim Hunter - citybuzz -

Jun 14, 2025
pulisher
Jun 13, 2025

Tonix Pharmaceuticals Announces Appointment of Commercial Indust - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Pharmaceuticals Appoints James “Jim” Hunter To Board - citybiz

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Pharmaceuticals (TNXP) Welcomes New Board Member | TNXP Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Pharma Appoints James Hunter to Board - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion? (NASDAQ:TNXP) - Seeking Alpha

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors | TNXP Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Tonix Strengthens Board with 40-Year Pharma Veteran as FDA Decision on Fibromyalgia Drug Approaches - Stock Titan

Jun 13, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals (TNXP) Files for $500M Mixed Securities Sh - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals stock falls after announcing $225 million share offerings By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals stock falls after announcing $225 million share offerings - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals (TNXP) Drops After $500M Shelf Filing - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares Tumble - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not Pessimistic By Stocktwits - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Oxford Industries, GameStop, Boeing And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals (TNXP) Files for $500M Mixed Securities Shelf | TNXP Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Tonix Pharmaceuticals Plans Potential Share Sale of Up to $150 Million; Stock Falls Premarket - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

Tonix Pharma Signs Major Sales Agreements for Funding - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Tonix Pharmaceuticals Holding May Sell Up To $150 Million In Common Stock - marketscreener.com

Jun 11, 2025
pulisher
Jun 11, 2025

Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO International Convention - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

(TNXP) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO Int - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention | TNXP Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Tonix Fibromyalgia Drug Faces Critical FDA Decision: CEO to Present Latest Data at BIO 2025 - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Analysis of Tonix Pharmaceuticals (TNXP) Stock: Performance, News for June 2025 - Investing.com India

Jun 10, 2025
pulisher
Jun 09, 2025

Tonix Pharmaceuticals doses first patient in Phase 2 OASIS trial for acute stress reaction - Proactive Investors

Jun 09, 2025
pulisher
Jun 06, 2025

Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025 - citybuzz -

Jun 06, 2025
pulisher
Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the Annua - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 | TNXP Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025 - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Tonix New Fibromyalgia Drug Shows Dual Sleep and Pain Benefits at EULAR 2025 | TNXP Stock News - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Tonix Pharmaceuticals (TNXP) Price Target Raised to $65 by Alliance Global Partners | TNXP Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 01, 2025

Wall Street Zen Downgrades Tonix Pharmaceuticals (NASDAQ:TNXP) to Sell - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Tonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky Bet (NASDAQ:TNXP) - Seeking Alpha

May 30, 2025
pulisher
May 29, 2025

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights - Revista ADVFN

May 29, 2025
pulisher
May 29, 2025

How the (TNXP) price action is used to our Advantage - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Tonix Pharmaceuticals (TNXP) Stock Surges Over 10%: What's Fueling the Rally and What's Next? - Daily Chhattisgarh News

May 29, 2025

Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
Kapitalisierung:     |  Volumen (24h):